[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100645038":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":7,"locations":7,"responsibleParty":12,"collaborators":7,"id":14,"slug":7,"hasResults":15,"nctId":16,"briefTitle":17,"officialTitle":17,"acronym":18,"eligibilityCriteria":19,"healthyVolunteers":15,"sex":20,"minAge":21,"maxAge":7,"enrollmentInfo":22,"targetDuration":7,"studyType":25,"phases":7,"briefSummary":26,"conditions":27,"keywords":29,"overallStatus":31,"whyStopped":7,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":7},{"fullName":5,"class":6},"University Hospital, Grenoble","OTHER",null,[9],{"type":10,"name":11,"description":11,"armGroupLabels":7,"otherNames":7},"PROCEDURE","Coronary catheterization",{"type":13,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100645038",false,"NCT07676201","One-year Prognostic Impact of Microcirculation Assessed by NH IMR Angio in Patients Hospitalized for Acute Myocarditis","MICROMYOC","Inclusion Criteria:\n\n* Male or female patients over the age of 18.\n* Patients hospitalized between June 2015 and July 2025.\n* Patients who presented with chest pain and at least 1 diagnostic criterion; or, in the absence of chest pain, at least 2 of the following diagnostic criteria:\n\n  * Electrocardiographic abnormalities (ST-segment elevation or depression, T-wave inversions, conduction disturbances such as type 3 atrioventricular block),\n  * Elevated troponin levels,\n  * Abnormal kinematics on echocardiography.\n* Associated with MRI findings of ≥2 tissue abnormalities (edema, hyperemia, myocardial fibrosis).\n* Coronary angiography performed during the initial hospitalization\n* Patient enrolled in or eligible for a social security program.\n* Patient who has expressed consent to participate.\n\nExclusion Criteria:\n\n* Absence of coronary artery disease confirmed by coronary angiography\n* Myocarditis secondary to immunotherapy\n* Presence of documented coronary artery disease (coronary angiography or cardiac CT)\n* Presence of cardiomyopathy (hypertrophic cardiomyopathy, dilated cardiomyopathy)\n* Infiltrative heart disease (sarcoidosis or cardiac amyloidosis)\n* Severe valvular heart disease\n* Takotsubo syndrome\n* Constrictive or chronic pericarditis\n* Loeffler's endocarditis\n* Left ventricular noncompaction\n* Cardiac tumor\n* Pulmonary embolism\n* Coronary spasm\n* Patients covered by Articles L1121-5 through L1121-8 of the Public Health Code (pregnant women, women in labor, and breastfeeding women; persons deprived of their liberty by judicial or administrative decision; adults under guardianship)","ALL","18 Years",{"count":23,"type":24},106,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to evaluate the association between post-coronary angiography IMR and medium-term clinical prognosis in patients with acute myocarditis. The main question it aims to answer is:\n\nIs there a correlation between impaired microcirculation and the occurrence of serious clinical events in this population of patients?",[28],"Myocarditis Acute",[30,11],"NH IMR","NOT_YET_RECRUITING","2026-06-23",{"date":34,"type":35},"2026-06-30","ACTUAL",{"date":37,"type":24},"2026-07-15",{"date":39,"type":24},"2026-10-15",{"name":5,"class":6}]